Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection

Structure mapping of dengue and Zika viruses reveals functional long-range interactions

(2019) Roland G. Huber et al.   Nature Communications

RNA and Toll-Like Receptor 7 License the Generation of Superior Secondary Plasma Cells at Multiple Levels in a B Cell Intrinsic Fashion

(2019) Caroline C. Krueger et al.   Frontiers in Immunology

Biosensor-based selective detection of Zika virus specific antibodies in infected individuals

(2018) Gustavo Cabral-Miranda et al.   BIOSENSORS & BIOELECTRONICS

Prevalence of Guillain-Barré syndrome among Zika virus infected cases: a systematic review and meta-analysis

(2018) Ludovica Barbi et al.   Brazilian Journal of Infectious Diseases

Zika virus vaccines: immune response, current status, and future challenges

(2018) Justin M Richner et al.   CURRENT OPINION IN IMMUNOLOGY

Development of vaccines against Zika virus

(2018) Gregory A Poland et al.   LANCET INFECTIOUS DISEASES

Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?

(2018) Miguel A. Martín-Acebes et al.   Frontiers in Cellular and Infection Microbiology

Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection

(2018) Rekha Khandia et al.   Frontiers in Immunology

Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation

(2018) Alan D. T. Barrett   npj Vaccines

Clinical manifestations of dengue in relation to dengue serotype and genotype in Malaysia: A retrospective observational study

(2018) Jeyanthi Suppiah et al.   PLoS Neglected Tropical Diseases

Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages

(2018) Matthew G. Zimmerman et al.   Cell Host & Microbe

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization

(2018) Emily N. Gallichotte et al.   Cell Reports

Current status of therapeutic and vaccine approaches against Zika virus

(2017) Braira Wahid et al.   European Journal of Internal Medicine

Major findings and recent advances in virus–like particle (VLP)-based vaccines

(2017) Mona O. Mohsen et al.   SEMINARS IN IMMUNOLOGY

Global evolutionary history and spatio-temporal dynamics of dengue virus type 2

(2017) Kaifa Wei et al.   Scientific Reports

Increased rates of Guillain-Barré syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil

(2017) Ashley R. Styczynski et al.   PLoS Neglected Tropical Diseases

Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer’s and cat allergy

(2017) Andris Zeltins et al.   npj Vaccines

Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice

(2017) Ming Yang et al.   Scientific Reports

Structural Basis of Zika Virus-Specific Antibody Protection

(2016) Haiyan Zhao et al.   CELL

Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016

(2016) Luisa Barzon et al.   Eurosurveillance

Dengue virus (DENV)-specific antibodies enhance Brazilian Zika virus (ZIKV) infection

(2016) Priscila MS Castanha et al.   JOURNAL OF INFECTIOUS DISEASES

Zika Virus–Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro

(2016) Anna B. Kawiecki et al.   JOURNAL OF INFECTIOUS DISEASES

Zika virus: a new challenge for blood transfusion

(2016) Didier Musso et al.   LANCET

Zika virus and microcephaly: why is this situation a PHEIC?

(2016) David L Heymann et al.   LANCET

Late sexual transmission of Zika virus related to persistence in the semen

(2016) Jean Marie Turmel et al.   LANCET

Zika virus in semen of a patient returning from a non-epidemic area

(2016) Jean Michel Mansuy et al.   LANCET INFECTIOUS DISEASES

Structural basis of potent Zika–dengue virus antibody cross-neutralization

(2016) Giovanna Barba-Spaeth et al.   NATURE

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

(2016) Wanwisa Dejnirattisai et al.   NATURE IMMUNOLOGY

Zika Virus

(2016) Lyle R. Petersen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

(2016) Lalita Priyamvada et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

(2016) P. Abbink et al.   SCIENCE

Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

(2016) K. Stettler et al.   SCIENCE

Recent Advances of Vaccine Adjuvants for Infectious Diseases

(2015) Sujin Lee et al.   Immune Network

Viral Particles Drive Rapid Differentiation of Memory B Cells into Secondary Plasma Cells Producing Increased Levels of Antibodies

(2014) F. Zabel et al.   JOURNAL OF IMMUNOLOGY

Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform

(2013) Oliver Pérez et al.   Frontiers in Immunology

Dynamics of Dengue Disease Severity Determined by the Interplay Between Viral Genetics and Serotype-Specific Immunity

(2011) M. OhAinle et al.   Science Translational Medicine

Complement-Mediated Neutralization of Dengue Virus Requires Mannose-Binding Lectin

(2011) P. Avirutnan et al.   mBio

Direct Complement Restriction of Flavivirus Infection Requires Glycan Recognition by Mannose-Binding Lectin

(2010) Anja Fuchs et al.   Cell Host & Microbe

Cutting Edge: IL-21 and TLR Signaling Regulate Germinal Center Responses in a B Cell-Intrinsic Manner

(2010) J. Bessa et al.   JOURNAL OF IMMUNOLOGY

Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

(2010) W. Dejnirattisai et al.   SCIENCE

A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice

(2010) Gunther Spohn et al.   Virology Journal

Pan-Dengue Virus Detection by PCR for Travelers Returning from the Tropics

(2008) A. Dumoulin et al.   JOURNAL OF CLINICAL MICROBIOLOGY